Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia.
Fujino
Junya
J
Department of Neuropsychiatry, Asakayama Hospital, Imaike-cho, Sakai Ward, Sakai Osaka, Japan. jjjjj1234567jp@hotmail.co.jp
Tanaka
Hideki
H
Taniguchi
Norio
N
Tabushi
Kaoru
K
D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000068180:Aripiprazole; D002908:Chronic Disease; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use*; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use*; D012563:Schizophrenia, Paranoid / Q000150:complications* / Q000188:drug therapy*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D007980:Levodopa; D000068180:Aripiprazole